Stakeholder Engagements Forum
Regulatory Requirements for the MRSA 2026 Act and General Regulations
Botswana Medicines Regulatory Authority (BoMRA) cordially invites all stakeholders to a consultative hybrid stakeholder engagement meeting aimed at strengthening collaboration and enhancing understanding of the regulatory framework for regulated products in Botswana.
Sessions Will Cover
- The Medicines and Related Substances (MRS) Act 2025
- All Draft Regulations, 2026
- Draft Fees, Levies & Penalties Regulations, 2026
Target Audience
The engagement targets stakeholders dealing with products regulated by the Botswana Medicines Regulatory Authority (BoMRA), including:
- Marketing Authorization Holders
- Local Technical Representatives
- Healthcare Facilities
- Healthcare Professional Associations
- Retailers
- Importers and Import Control
- Manufacturers
- Distributors
- Wholesalers
- Local Authorized Representatives
Hybrid Stakeholder Engagement Schedule
26 August 2026 — Act and General Regulations
31 August 2026 — Human Medicines + Clinical Trials
3 September 2026 — Veterinary Medicines + Clinical Trials (rescheduled from 27 August)
10 September 2026 — Medical Devices + Clinical Trials
Attendance & RSVP
Time: 08:30 – 17:00 hrs
Format: Hybrid – in person and virtual
Virtual Attendance: The virtual attendance link will be shared with participants in due course.
Stakeholders wishing to attend in person are kindly requested to confirm attendance by completing the online RSVP form or by emailing: